L-RNA aptamer-based CXCL12 inhibition combined with radiotherapy in newly-diagnosed glioblastoma: dose escalation of the phase I/II GLORIA trial.
Giordano FA, Layer JP, Leonardelli S, Friker LL, Turiello R, Corvino D, Zeyen T, Schaub C, Müller W, Sperk E, Schmeel LC, Sahm K, Oster C, Kebir S, Hambsch P, Pietsch T, Bisdas S, Platten M, Glas M, Seidel C, Herrlinger U, Hölzel M.
Giordano FA, et al. Among authors: bisdas s.
Nat Commun. 2024 May 28;15(1):4210. doi: 10.1038/s41467-024-48416-9.
Nat Commun. 2024.
PMID: 38806504
Free PMC article.
Clinical Trial.